ArticleJMA journal2025
Trends in Medical Expenses for Ocular Examinations in Japan Based on Nationwide Database Studies.
Article in JMA journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Age-Specific Increases in the Prevalence and Treatment Burden of Neovascular Age-Related Macular Degeneration in a Super-Aged Society.Investigative ophthalmology & visual science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Medical expenses, including ocular expenses, have been increasing annually in Japan. This study investigated national trends in the number of ocular examinations and examination expenses. Methods: This descriptive study used two national data sources: national medical expense estimates and statistics on medical care activities under public health insurance. We analyzed the medical expenses in Japan from 2008 to 2021 and estimated the proportions of different types of medical services. Results: Over 14 years, total medical expenses increased from 1.71 trillion yen to 2.31 trillion yen, with ocular medical expenses increasing from 64.5 billion yen to 96.0 billion yen. The total examination expenses increased from 155.2 billion yen to 231.5 billion yen, with ocular examination expenses increasing from 24.3 billion yen to 32.8 billion yen over 14 years. The examination expense category accounted for 32.3% of ocular medical expenses, although the overall examination expense category amounted to 10.0% of nationwide medical expenses in 2021. In particular, expenses related to optical coherence tomography (OCT) surged by 875.6%, visual field testing increased by 81.2%, corneal curvature measurement increased by 61.0%, and corneal endothelial cell density measurement increased by 59.3%. Only contact lens (CL) examination fees expenses decreased by 10.9%. In 2020, the coronavirus disease 2019 (COVID-19) pandemic caused a 24.8% and 22.0% decrease in ocular and nationwide examination expenses, respectively. Conclusions: Over 14 years, ocular medical expenses in Japan have increased by 49.0%, and nationwide medical expenses have increased by 35.1%. In addition, ocular examination expenses have increased by 35.0% over the past 14 years, although nationwide examination expenses have increased by 49.1%. All examination expenses increased except for CL examination fees. In particular, the OCT category witnessed a rapid increase. The COVID-19 pandemic has affected ocular examination expenses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.